Investment in Ontario drug discovery research will help develop new cancer medicines for patients
OICR announces support for five projects through its Cancer Therapeutics Innovation Pipeline (CTIP)
Excerpt from the Press Release:
Ontario research teams investigating new ways to treat cancer are taking the crucial next steps to bring their discoveries to patients thanks to support from the Ontario Institute for Cancer Research (OICR).
OICR announced it is funding five Ontario-based drug discovery projects between $150,000 and $300,000 per project through its Cancer Therapeutics Innovation Pipeline (CTIP) initiative. CTIP supports research into promising molecules that could become the next generation of cancer therapeutics.
This year’s cohort of CTIP projects aims to develop treatments for some of the most devastating cancers, including pancreatic cancer, ovarian cancer, breast cancer and late-stage prostate cancer.
Beyond funding, CTIP’s committee of experts from academia and industry advises research teams on the science and approaches needed to advance their discoveries, and the strategy to attract the partnerships and investments needed to bring a new drug to the clinic.
Click the button below to read the entire Press Release:
Discover What Sets TrialStat Apart From Ordinary EDC Platforms
Click the image or button below to explore our eClinical Suite Platform and discover what sets TrialStat apart from competing EDC platforms.
Request Your Demo Today!
From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?